<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="78974">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01968746</url>
  </required_header>
  <id_info>
    <org_study_id>602039</org_study_id>
    <nct_id>NCT01968746</nct_id>
  </id_info>
  <brief_title>The AVERT Sepsis Investigation</brief_title>
  <acronym>AVERT</acronym>
  <official_title>The AVERT Sepsis Investigation: Assessment of Variability in Early Resuscitation and Treatment of Sepsis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Christiana Care Health Services</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Therapeutic Monitoring Systems</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>MaRS Discovery District, Government of Ontario</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Christiana Care Health Services</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overall objective of this study is to utilize heart rate variability and respiratory
      rate variability in patients with sepsis to predict clinical deterioration and death.

      Our specific objectives are:

        1. To study the ability of a change in composite variability (∆CVI) assessment to act as a
           prognostic aid in predicting disease progression in sepsis.

        2. To study the effect that standard resuscitation interventions will have on the
           direction and magnitude of ∆CVI in patients with sepsis.

      B. Hypotheses H1: In the initial resuscitation of sepsis, a low or declining multi-parameter
      composite variability index (CVI) over 4 hours will predict a significant increase in the
      combined outcome of overt shock, organ dysfunction, and mortality.

      H2: In the initial resuscitation of sepsis, low volume fluid resuscitation (&lt;20 cc/kg) over
      4 hours will be associated with a low or declining CVI.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2012</start_date>
  <completion_date type="Anticipated">March 2015</completion_date>
  <primary_completion_date type="Anticipated">January 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Progressive organ failure</measure>
    <time_frame>72 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>A.	SOFA score increase by ≥ 1 from baseline B.	Overt shock C.	Mortality (all-cause, in-hospital)</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Sepsis</condition>
  <condition>Severe Sepsis</condition>
  <arm_group>
    <arm_group_label>ED patients with suspected infection</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients admitted through the ED for suspected infection as primary reason for admission.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  1. Antibiotics ordered or administered (as surrogate for suspected or confirmed
             infection as primary reason for hospital admission as determined by the primary team)
             2. Serum lactate ≥ 2.0 mmol/L or transient hypotension (any systolic blood pressure &lt;
             100 mmHg).

             3. Identification within 12 hours of a qualifying lactate measurement or hypotension
             episode 4. Hospital admission planned for suspected infection as primary reasons for
             admission (per emergency medicine team).

        Exclusion Criteria:

          -  1. Age &lt; 18 years 2. Pregnancy 3. Non-sinus cardiac rhythm (atrial fibrillation,
             active pacemaker, SVT) 4. Evidence of Overt Shock upon enrollment:

               -  Hypotension: SBP &lt; 90 mmHg for ≥ 60 minutes

               -  Any vasopressor or inotrope use (e.g. norepinephrine, dopamine, vasopressin,
                  dobutamine) 5. Acute respiratory support (BiPAP or mechanical ventilation)
                  before enrollment 6. Inability to obtain written informed consent from patient
                  or legally authorized representative 7. Inability to wear Zephyr Bioharness
                  device
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ryan Arnold, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Christiana Care Health Services</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Andrew JE Seely, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Ottawa Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ryan Arnold, MD</last_name>
    <phone>(302) 733-4130</phone>
    <email>RyArnold@christianacare.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Debra R Marco, RN</last_name>
    <phone>(302)733-4130</phone>
    <email>DMarco@christianacare.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Denver Health Medical Center</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80204</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeffrey Sankoff, MD</last_name>
    </contact>
    <investigator>
      <last_name>Jeffrey Sankoff, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Christiana Health System</name>
      <address>
        <city>Newark</city>
        <state>Delaware</state>
        <zip>19718</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Debra R. Marco, RN</last_name>
      <phone>302-733-4130</phone>
      <email>DMarco@christianacare.org</email>
    </contact>
    <contact_backup>
      <last_name>Ryan Arnold, MD</last_name>
      <phone>302-733-4130</phone>
      <email>RyArnold@christianacare.org</email>
    </contact_backup>
    <investigator>
      <last_name>Christian Coletti, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ryan Arnold, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Billings Clinic</name>
      <address>
        <city>Billings</city>
        <state>Montana</state>
        <zip>59101</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Randy Thompson, MD</last_name>
    </contact>
    <investigator>
      <last_name>Randy Thompson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cooper University Hospital</name>
      <address>
        <city>Camden</city>
        <state>New Jersey</state>
        <zip>08103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>The Ottawa Hospital</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sean Moore</last_name>
    </contact>
    <contact_backup>
      <last_name>Geoff Green, MD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Sean Moore, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christophe Herry, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andrew JE Seely, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andrea Bravi</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
    <country>Canada</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>October 21, 2013</lastchanged_date>
  <firstreceived_date>October 21, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Sepsis</keyword>
  <keyword>Shock</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
